Cargando…
Efficacy and Safety of Sitafloxacin in Treating Low-risk Febrile Neutropenia in Patients with Lung Cancer
INTRODUCTION: Febrile episodes in patients with cancer and chemotherapy-induced neutropenia can be life-threatening and generally require prompt administration of broad-spectrum antimicrobials. However, little evidence exists for treating patients with solid tumors and febrile neutropenia (FN) with...
Autores principales: | On, Rintaro, Matsumoto, Takemasa, Ebi, Noriyuki, Doi, Seiji, Ishii, Hiroshi, Furugen, Makoto, Fujita, Jiro, Ide, Maako, Kishimoto, Junji, Okamoto, Isamu, Fujita, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358298/ https://www.ncbi.nlm.nih.gov/pubmed/35992295 http://dx.doi.org/10.31662/jmaj.2021-0227 |
Ejemplares similares
-
Preliminary Evaluation of a Sitafloxacin-Containing Regimen for Relapsed or Refractory Pulmonary Mycobacterium avium Complex Disease
por: Fujita, Kohei, et al.
Publicado: (2016) -
Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan
por: Hirano, Ryosuke, et al.
Publicado: (2018) -
Prevalence of viral infection in acute exacerbation of interstitial lung diseases in Japan
por: On, Rintaro, et al.
Publicado: (2020) -
TNFR1 Mediated Apoptosis Is Protective against Mycobacterium avium in Mice
por: Shundo, Yuki, et al.
Publicado: (2023) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)